The deal priced at yesterday’s closing price. Evercore ISI, Stifel and Oppenheimer are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VOR:
- Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
- Vor Bio prices underwritten offering of common stock, private placement
- First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
- Vor Bio announces first AML patient successfully transplanted with VOR33
- 2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15